Correlation Between Pacer Financial and Loncar Cancer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pacer Financial and Loncar Cancer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacer Financial and Loncar Cancer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacer Financial and Loncar Cancer Immunotherapy, you can compare the effects of market volatilities on Pacer Financial and Loncar Cancer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacer Financial with a short position of Loncar Cancer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacer Financial and Loncar Cancer.

Diversification Opportunities for Pacer Financial and Loncar Cancer

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pacer and Loncar is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pacer Financial and Loncar Cancer Immunotherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Loncar Cancer Immuno and Pacer Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacer Financial are associated (or correlated) with Loncar Cancer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Loncar Cancer Immuno has no effect on the direction of Pacer Financial i.e., Pacer Financial and Loncar Cancer go up and down completely randomly.

Pair Corralation between Pacer Financial and Loncar Cancer

Given the investment horizon of 90 days Pacer Financial is expected to generate 0.22 times more return on investment than Loncar Cancer. However, Pacer Financial is 4.63 times less risky than Loncar Cancer. It trades about 0.26 of its potential returns per unit of risk. Loncar Cancer Immunotherapy is currently generating about 0.0 per unit of risk. If you would invest  3,867  in Pacer Financial on September 2, 2024 and sell it today you would earn a total of  136.00  from holding Pacer Financial or generate 3.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy46.88%
ValuesDaily Returns

Pacer Financial  vs.  Loncar Cancer Immunotherapy

 Performance 
       Timeline  
Pacer Financial 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Pacer Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively inconsistent basic indicators, Pacer Financial may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Loncar Cancer Immuno 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Loncar Cancer is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pacer Financial and Loncar Cancer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pacer Financial and Loncar Cancer

The main advantage of trading using opposite Pacer Financial and Loncar Cancer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacer Financial position performs unexpectedly, Loncar Cancer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will offset losses from the drop in Loncar Cancer's long position.
The idea behind Pacer Financial and Loncar Cancer Immunotherapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities